|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/20 | |
| A61K 31/485 | |||
| C07D 489/08 |
| (11) | Patento numeris | 2371357 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11157837.3 |
| Europos patento paraiškos padavimo data | 2011-03-11 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-10-05 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-02-01 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 313018 P | 2010-03-11 | US |
| (72) |
Shah, Syed M., US
Diorio, Christopher Richard, US
Ehrnsperger, Eric C., US
Meng, Xu, US
Shareffi, Kadum A., US
Cohen, Jonathan Marc, US
|
| (73) |
Wyeth LLC,
235 East 42nd Street, New York, NY 10017,
US
|
| (54) | Oral formulations and lipophilic salts of methylnaltrexone |
| Oral formulations and lipophilic salts of methylnaltrexone |